This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Successfully Balancing The Needs of The Planet With The Needs of The Patient
Publications, Pharmaceutical, Sustainability, Innovation & Insights, Drug Delivery Innovations, Product Solutions
Using digital healthcare to improve patient compliance and adherence
Webinars, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Introducing PureHale® for targeted upper respiratory tract care
Webinars, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions
Aptar Pharma talks targeted drug delivery to the upper airways
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Product Solutions
